top of page
Weight Loss Injections

Semaglutide
FDA-approved GLP-1 therapy (the active ingredient in Ozempic® & Wegovy®). Potently reduces appetite, slows gastric emptying, and promotes steady, sustainable fat loss (15-20% body weight in studies). Also improves blood sugar, heart health, and energy. Administered weekly via tiny injection. Perfect for medical weight loss with life-changing results.
Tirzepatide
The breakthrough dual GLP-1/GIP therapy (active ingredient in Mounjaro® & Zepbound®). Delivers superior appetite control and up to 22% body weight loss in clinical trials—outperforming semaglutide. Weekly injection also lowers blood sugar, improves insulin sensitivity, and supports heart health. Transformative, sustainable results with minimal side effects.

bottom of page
